(Q77671013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

D Vervloet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

T Ekström

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R Pela

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

F Duce Gracia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C Kopp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

B D Silvert

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Quebe-Fehling

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Della Cioppa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Di Benedetto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

836-842

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990385-7

7 January 2021

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990385-7

7 January 2021

Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990385-7

7 January 2021

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990385-7

7 January 2021

Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990385-7

7 January 2021

Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990385-7

7 January 2021

Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2898%2990385-7

7 January 2021

10.1016/S0954-6111(98)90385-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9850367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference